Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): Protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the United Kingdom

Timothy S. Walsh*, Leanne M Aitken, Cathrine McKenzie, Julia Boyd, Alix Macdonald, Annabel Giddings, David Hope, John Norrie, Christopher J Weir, Richard A Parker, Nazir I Lone, Lydia M Emerson, Kalliopi Kydonaki, Ben Creagh-Brown, Stephen Morris, Danny F. McAuley, Paul Dark, Matt P. Wise, Anthony C Gordon, Gavin D PerkinsMichael C. Reade, Bronagh Blackwood, Alasdair M J MacLullich, Robert Glen, Valerie J Page

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): Protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the United Kingdom'. Together they form a unique fingerprint.

Nursing and Health Professions

Medicine and Dentistry